Kodiak Sciences (KOD) Other Non-Current Liabilities (2017 - 2026)
Kodiak Sciences (KOD) posted Other Non-Current Liabilities of $100.0 million for Q1 2026, little changed on a QoQ basis from $100.0 million in Q4 2025, and little changed year-over-year from $100.0 million in Q1 2025.
Kodiak Sciences (KOD) Other Non-Current Liabilities (2017 - 2026) Analysis & Trends
Kodiak Sciences' Other Non-Current Liabilities history runs 10 years deep, the most recent figure standing at $100.0 million for Q1 2026.
- Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $100.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $100.0 million, changed 0.0% from the prior year.
- Other Non-Current Liabilities was $100.0 million for Q1 2026 at Kodiak Sciences, roughly flat from $100.0 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $100.0 million in Q4 2023 and bottomed at $175000.0 in Q3 2022.
- A 5-year average of $78.6 million and a median of $100.0 million in 2023 frame the typical range for Other Non-Current Liabilities.
- Peak annual rise in Other Non-Current Liabilities reached 47291.47% in 2022, while the deepest fall reached 99.82% in 2022.
- Kodiak Sciences' Other Non-Current Liabilities stood at $100.0 million in 2022, then advanced by 0.0% to $100.0 million in 2023, then changed by 0.0% to $100.0 million in 2024, then changed by 0.0% to $100.0 million in 2025, then changed by 0.0% to $100.0 million in 2026.
- Business Quant data shows KOD's Other Non-Current Liabilities at $100.0 million in Q1 2026, $100.0 million in Q4 2025, and $100.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Kodiak Sciences | 2.54 Bn | 2.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 100.00 Mn |
| Sep 30, 2025 | 100.00 Mn |
| Jun 30, 2025 | 100.00 Mn |
| Mar 31, 2025 | 100.00 Mn |
| Dec 31, 2024 | 100.00 Mn |
| Sep 30, 2024 | 100.00 Mn |
| Jun 30, 2024 | 100.00 Mn |
| Mar 31, 2024 | 100.00 Mn |
| Dec 31, 2023 | 100.00 Mn |
| Dec 31, 2022 | 100.00 Mn |
| Sep 30, 2022 | 175,000.00 |
| Jun 30, 2022 | 187,000.00 |
| Mar 31, 2022 | 199,000.00 |
| Dec 31, 2021 | 211,000.00 |
| Sep 30, 2021 | 99.93 Mn |
| Jun 30, 2021 | 234,000.00 |
| Mar 31, 2021 | 245,000.00 |
| Dec 31, 2020 | 99.89 Mn |
| Sep 30, 2020 | 267,000.00 |